Perfusi is developing a non-invasive monitoring solution to track tissue perfusion during and after surgery, helping clinicians recognize and prevent tissue damage in real time. The company aims to make continuous blood flow monitoring a standard part of intra- and postoperative care using conventional technology. Their platform is currently in development, with more details expected to be released soon.
Funding
Funding not disclosed
Founders
Product
Problem
Tissue perfusion—the flow of blood through tissues—is a critical parameter that must be monitored during and after surgery to recognize and prevent tissue damage. However, current monitoring methods are often invasive, intermittent, or require specialized equipment, leaving gaps in real-time awareness of perfusion status during critical perioperative periods.
Solution
Perfusi is developing a solution to make continuous monitoring of tissue perfusion during and after surgery a practical reality using conventional non-invasive technology. The platform is designed to track intra- and postoperative blood flow, providing clinicians with ongoing visibility into tissue health without the need for invasive procedures. By leveraging standard, accessible technology, Perfusi aims to integrate perfusion monitoring seamlessly into existing surgical workflows, enabling earlier detection of compromised tissue and more timely interventions.
Target Audience
Primary users are surgeons, anesthesiologists, and perioperative care teams in hospital settings who need continuous tissue perfusion data to guide clinical decisions during and after surgery.
Features
- Non-invasive monitoring approach using conventional technology to avoid additional patient risk
- Designed for continuous use during both intraoperative and postoperative phases
- Focus on real-time blood flow tracking to support early recognition of tissue damage
- Integration potential with standard surgical and recovery workflows